Rockefeller Institute first in the U.S. to enroll patient in stroke trial
BY WVU MEDICINE The WVU Rockefeller Neuroscience Institute was the first institution in the United States to enroll a patient in the Route92 Medical Inc. SUMMIT MAX clinical trial. SUMMIT MAX is a randomized, controlled, multicenter trial to evaluate the performance of its next generation Monopoint™ Reperfusion System versus currently available aspiration catheter technology. The trial’s first patient was enrolled at Auckland City Hospital in New Zealand, followed shortly by a patient at the WVU Rockefeller Neuroscience Institute. “We are happy to become the first U.S. ...